- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05220839
Relation of the Area of Cerclage With Preterm Birth
February 16, 2022 updated by: Neval Cayonu, Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital
Is the Cerclage Area Associated With the Incidence of Preterm Birth in Pregnant Women Undergoing Mc Donald Cerclage?
This study is planned prospectively in pregnancies who applied to Etlik Zübeyde Hanım Women's Health Care, Training and Research Hospital which is a teritiary hospital with 15.000 births anually, between January 2022 and January 2023.
Cerclage treatment will be performed with the McDonald technique (the type of cerclage suture will be mersilene) between the 16-23 weeks of gestation in pregnant women with a diagnosis of cervical insufficiency based on the history , physical examination or ultrasound findings according to ACOG.
The investigators will measure cerclage area after cerclage treatment (within 0-4 weeks) and different parameters besides it by transvaginal ultrasound.
It will be whether the collected data is related to the incidence of preterm birth.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The parameters that will be measured with transvaginal ultrasound are:
- Cerclage area in the axial plane of the cervix
- Angle between anterior uterine wall and internal os
- Angle between anterior uterine wall and external os
- Anterior and posterior cervical widht at level of stitch
- Anterior and posterior stitch depth (stitch to canal )
- Cervical length above and below cerclage stitch
Before the data collection phase ,the required sample number for the research was determined using the G*power (Faul, Erdfelder, Buchner, & Lang, 2009) 3.1 program. When the alpha level is .05 and the power is %95 , the total number of samples was found o be 22.
Study Type
Observational
Enrollment (Anticipated)
22
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Neval Çayönü Kahraman, MD
- Phone Number: +905336212174
- Email: nevalcayonu@gmail.com
Study Contact Backup
- Name: Mehmet Obut, MD
- Phone Number: +905056710339
- Email: drmehmetobut@hotmail.com
Study Locations
-
-
Keçiören
-
Ankara, Keçiören, Turkey, 06010
- Recruiting
- Etlik Zubeyde Hanım Women's Health Training and Research hospital
-
Contact:
- Neval Çayönü Kahraman, MD
- Phone Number: +905336212174
- Email: nevalcayonu@gmail.com
-
Contact:
- Mehmet Obut, MD
- Phone Number: +905056710339
- Email: drmehmetobut@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Patients aged between 18-45 years old, have not any maternal chronic ilnesses, have not amnion fluid abnormalities, underwent cervical cerclage according to ACOC criteria between 16-23 gestational weeks.
Description
Inclusion Criteria:
- Singleton pregnancy between 16-23 weeks of gestation and between the ages of 18-45
- According to ACOG based on history (Having one or more painless abortions between 16-22 weeks of gestation , a history of cerclage
- According to ACOG based on physical examination ( fetal membranes prolapsed from endocervical canal or not, cervical dilation present )
- Accoding to ACOG based on ultrasound examination ( if there is no previous history of preterm birth , if the cervical length is 10mm or less, if the cervical length is less than 25mm with a history of preterm birth )
Exclusion Criteria:
- Multiple pregnancies
- Pregnant women with premature rupture of membranes
- Pregnant women with uterine anomalies
- Pregnant women with fetal anomalies
- Pregnant women with Gestational diabetes mellitus, Chronic or gestational hypertension , fetal growth restriction , oligohydroamnios or polihydroamnios
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cervical cerclage area
Time Frame: Between 16-23 weeks of pregnancy
|
cervical cerclage will be measured in the axial plane of the cervix by transvaginal ultrasonography
|
Between 16-23 weeks of pregnancy
|
|
Preterm birth
Time Frame: From date of cervical cerclage to delivery
|
The incidence of patients delivered before 37. gestational weeks
|
From date of cervical cerclage to delivery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Can Tekin Iskender, MD, Helath Sciences University, Etlik Zubeyde Hanım Women's Health Training and Research Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kahraman N, Obut M. Area of cervical cerclage
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 21, 2022
Primary Completion (Anticipated)
January 21, 2023
Study Completion (Anticipated)
February 23, 2023
Study Registration Dates
First Submitted
January 21, 2022
First Submitted That Met QC Criteria
January 21, 2022
First Posted (Actual)
February 2, 2022
Study Record Updates
Last Update Posted (Actual)
March 4, 2022
Last Update Submitted That Met QC Criteria
February 16, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021/132
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cervical Insufficiency
-
Hospices Civils de LyonCompletedCervical Insufficiency | Cerclage, CervicalFrance
-
Intermountain Women and Children's ResearchUnknownCervical InsufficiencyUnited States
-
Northwestern UniversityCompleted
-
Maternal-Infantil Vall d´Hebron HospitalCompletedCervical InsufficiencySpain
-
Luzerner KantonsspitalCompletedCervical Insufficiency | Cervical StiffnessSwitzerland
-
Wake Forest University Health SciencesNot yet recruiting
-
Zeynep Kamil Maternity and Pediatric Research and...Unknown
-
Galena Innovations, LLCNot yet recruitingPreterm Birth | Cervical Insufficiency | Short Cervix | Cervical Incompetence | Soft CervixUnited States
-
Kaplan Medical CenterRabin Medical Center; Meir Medical Center; Wolfson Medical Center; Clalit Health...Not yet recruitingPreterm Delivery | Cervical Insufficiency | Cervical CerclageIsrael
-
Tufts Medical CenterPregnolia AGCompletedPreterm Birth | Pregnancy Related | Cervical InsufficiencyUnited States
Clinical Trials on Type of cerclage procedure Mc Donald
-
Başakşehir Çam & Sakura City HospitalCompletedCervical Incompetence (Complicating Pregnancy)Turkey
-
Juan AmeztoyActive, not recruitingShoulder Instability | Anterior Shoulder Instability | Latarjet | Shoulder | Anterior Shoulder DislocationSpain
-
Ohio State University Comprehensive Cancer CenterNot yet recruitingPancreatic Neuroendocrine Tumor | Pancreatic NeoplasmUnited States
-
Second Affiliated Hospital of Wenzhou Medical UniversityCompleted
-
Hôpital Edouard HerriotUnknown
-
M.D. Anderson Cancer CenterRecruitingMetastatic Malignant Neoplasm in the Liver | Primary Malignant Liver Neoplasm | Liver and Intrahepatic Bile Duct NeoplasmUnited States
-
Ankara City Hospital BilkentRecruitingPudendal NeuralgiaTurkey (Türkiye)
-
Federal University of São PauloUnknown
-
Mayo ClinicActive, not recruitingEvaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF TrialProstate CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingAdvanced Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Metastatic Hepatocellular CarcinomaUnited States